{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:55:33Z","timestamp":1792043733919,"version":"4.4.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Search-and-treat strategy for <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic> and surveillance of patients with precancerous lesions are recommended to decrease the burden of gastric cancer in high-risk areas. We aimed to evaluate the acceptance of the target population to these strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We applied a search-and-treat strategy combined with biomarker screening (pepsinogens I and II, gastrin-17) for atrophic gastritis to healthy individuals aged 40\u201364\u2009years within the GISTAR Pilot study. Different means of invitation were evaluated \u2013 direct telephone calls, letters of invitation via the general practitioners. Participants with altered biomarker results were invited to undergo upper gastrointestinal endoscopy. <jats:italic toggle=\"yes\">H.pylori<\/jats:italic> positive individuals were offered eradication therapy. Data on the compliance to the treatment and reasons for noncompliance were collected via telephone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Altogether 3453 participants were enrolled. The attendance of women participants was 1.9 times higher although active invitation strategies were mainly targeting men. The yield for the telephone invitations was higher than for mail-delivered invitations (2.1 calls vs. 7.7 letters required to recruit one study subject). Out of 661 individuals reached with the invitation to undergo upper endoscopy, 520 (78.7%) attended the procedure. Out of 1185 study subjects eligible for eradication, 810 (68.4%) accepted it. Of those having received the medication, 765(94.4%) completed it. The reasons for nonparticipation were the overall misconception of the importance of screening, busy schedule and others.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>While only the minority of the target population participated in the gastric cancer prevention strategy, relatively high compliance was seen among the participants. The acceptance rate and the identified reasons for refusing to participate in our study indicate that there is a need to raise gastric cancer awareness and its existent preventive strategies within the general population for their successful implementation in the community.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000682","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T16:01:49Z","timestamp":1631635309000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Factors influencing participation in preventive interventions for gastric cancer: the results from the GISTAR study"],"prefix":"10.1097","volume":"31","author":[{"given":"M\u0101rcis","family":"Leja","sequence":"first","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"},{"name":"Department of Research, Riga East University hospital"},{"name":"Digestive Diseases Centre GASTRO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Cine","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inese","family":"Po\u013caka","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"},{"name":"Institute of Information Technology, Riga Technical University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva","family":"Daugule","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Murillo","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), Lyon, France"},{"name":"Centro Javeriano de Oncolog\u00eda, Hospital Universitario San Ignacio. Bogot\u00e1, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Parshutin","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"},{"name":"Institute of Information Technology, Riga Technical University, Riga, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danute","family":"Ra\u017euka-Ebela","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rotberga","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Anarkulova","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kri\u0137e","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiga","family":"\u0160antare","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"},{"name":"Department of Research, Riga East University hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Tzivian","sequence":"additional","affiliation":[{"name":"Institute of Clinical and Preventive Medicine and Faculty of Medicine, University of Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), Lyon, France"},{"name":"Agencia Costarricense de Investigaciones Biom\u00e9dicas, Fundaci\u00f3n INCIENSA, San Jose, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Young","family":"Park","sequence":"additional","affiliation":[{"name":"International Agency for Research on Cancer (IARC), Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-013-0897-8","article-title":"Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan.","volume":"49","author":"Asaka","year":"2014","journal-title":"J Gastroenterol"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/fampra\/cmr020","article-title":"Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients.","volume":"28","author":"Aubin-Auger","year":"2011","journal-title":"Fam Pract"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/ijc.23208","article-title":"Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer.","volume":"122","author":"Blom","year":"2008","journal-title":"Int J Cancer"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2741\/4210","article-title":"Molecular diagnostics in gastric cancer.","volume":"19","author":"Bornschein","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/13548506.2018.1437278","article-title":"The incremental role of trait emotional intelligence on perceived cervical screening barriers.","volume":"23","author":"Costa","year":"2018","journal-title":"Psychol Health Med"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ypmed.2019.03.025","article-title":"A 3-step intervention to improve adherence to cervical cancer screening: the SCAN randomized controlled trial.","volume":"123","author":"Firmino-Machado","year":"2019","journal-title":"Prev Med"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.","volume":"24","author":"Fock","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/antibiotics9100671","article-title":"Transitioning of Helicobacter pylori therapy from trial and error to antimicrobial stewardship.","volume":"9","author":"Graham","year":"2020","journal-title":"Antibiotics"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gutjnl-2020-322385","article-title":"European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners.","volume":"70","author":"Graham","year":"2021","journal-title":"Gut"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/chp.47","article-title":"Lost in knowledge translation: time for a map?","volume":"26","author":"Graham","year":"2006","journal-title":"J Contin Educ Health Prof"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.0887-378X.2004.00325.x","article-title":"Diffusion of innovations in service organizations: systematic review and recommendations.","volume":"82","author":"Greenhalgh","year":"2004","journal-title":"Milbank Q"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.2014.10498","article-title":"Prevention of gastric cancer.","volume":"312","author":"Herrero","year":"2014","journal-title":"JAMA"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejon.2012.02.004","article-title":"Barriers to breast cancer screening participation among Jordanian and Palestinian American women.","volume":"17","author":"Kawar","year":"2013","journal-title":"Eur J Oncol Nurs"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2296-9-15","article-title":"Barriers to colorectal cancer screening in community health centers: a qualitative study.","volume":"9","author":"Lasser","year":"2008","journal-title":"BMC Family Pract"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1007\/s10620-019-05893-z","article-title":"What would the screen-and-treat strategy for Helicobacter pylori mean in terms of antibiotic consumption?","volume":"65","author":"Leja","year":"2020","journal-title":"Dig Dis Sci"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bpg.2014.09.005","article-title":"Implementation of gastric cancer screening - the global experience.","volume":"28","author":"Leja","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"e016999","DOI":"10.1136\/bmjopen-2017-016999","article-title":"Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study.","volume":"7","author":"Leja","year":"2017","journal-title":"BMJ Open"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus.","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report.","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3332\/ecancer.2020.1146","article-title":"A review of barriers and facilitators to mammography in Asian women.","volume":"14","author":"Momenimovahed","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gutjnl-2020-321372","article-title":"European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21\u2009533 patients.","volume":"70","author":"Nyssen","year":"2021","journal-title":"Gut"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3390\/ijerph15081677","article-title":"Barriers to breast cancer screening among diverse cultural groups in Melbourne, Australia.","volume":"15","author":"O\u2019Hara","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"R23-20250527","first-page":"e165","article-title":"Trial profile: pilot study of the multicentre randomised trial of H.pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (the GISTAR Pilot study).","volume":"1","author":"Park","year":"2019","journal-title":"Microb Health Dis"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.","volume":"51","author":"Pimentel-Nunes","year":"2019","journal-title":"Endoscopy"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MEG.0000000000000314","article-title":"Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.","volume":"27","author":"Santare","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/codi.14707","article-title":"Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.","volume":"21","author":"Selva","year":"2019","journal-title":"Colorectal Dis"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000445229","article-title":"Strategies for prevention of gastric cancer: progress from mass eradication trials.","volume":"34","author":"Sugano","year":"2016","journal-title":"Dig Dis"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis.","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"key":"R29-20250527","first-page":"647","article-title":"Slovenian society for gastroenterology and hepatology guidelines on the management of Helicobacter pylori infection.","volume":"80","author":"Tepe\u0161","year":"2011","journal-title":"Zdrav Vestn"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ejca.2013.03.007","article-title":"What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?","volume":"49","author":"van Dam","year":"2013","journal-title":"Eur J Cancer"},{"key":"R31-20250527","first-page":"51","article-title":"European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.","volume":"45","author":"von Karsa","year":"2013","journal-title":"Endoscopy"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:06:22Z","timestamp":1748361982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000682","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}